Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

In connection with the offering, Modular Medical has granted the underwriter a 30-day option to purchase up to an additional 15% of common shares and/or warrants at the public offering price, less ...

SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed ...

TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on ...

Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...

The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi mobile application. The app is designed to securely connect with the ...

Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with diabetes ...

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. resulting from allegations that ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

SAN DIEGO - Tandem Diabetes Care, Inc. (NASDAQ:TNDM), currently trading at $12 per share with annual revenues exceeding $1 billion, announced Monday that its t:slim X2 insulin pump with Control-IQ+ ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker ...